|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.50 EUR | 0.00% |
|
+3.38% | -9.24% |
| 04-22 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 04-05 | Boiron SA announces Annual dividend, payable on June 05, 2026 | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Manufacture and Marketing of Homeopathic Medicines & Other Healthcare Solutions | 455M | 534M | 493M | 488M | 501M | |||||
Total Assets | 771M | 789M | 590M | 576M | 603M | |||||
Interest Expense | -359K | -607K | -1.19M | -1.22M | -1.11M | |||||
Income Tax Expense | 17.55M | 14.92M | 12.91M | 3.24M | 10.22M | |||||
CAPEX | -20.42M | -18.59M | -9.86M | -8.4M | -15.48M | |||||
EBT | 46.11M | 59.2M | 46.85M | 14.58M | 42.86M | |||||
D&A | 25.64M | 23.26M | 23.97M | 22.63M | 10.24M | |||||
Operating Income | 46.84M | 63.45M | 42.29M | 15.74M | 43.67M | |||||
Net Income | 28.56M | 44.67M | 35.83M | 11.34M | 32.64M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
France | 327M | 395M | 342M | 341M | 344M | |||||
Total Assets | 748M | 775M | 574M | 564M | 576M | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | 12.76M | 12.03M | 9.03M | 2.25M | 7.87M | |||||
D&A | 29.88M | 32.17M | 34.09M | 27.08M | - | |||||
CAPEX | -19.32M | -17.48M | -16.69M | -13.72M | -14.68M | |||||
Net Income | 16.7M | 37.35M | 27.69M | 10.79M | 26.73M | |||||
Operating Income | 29.98M | 52.55M | 29.89M | 14.07M | 34.72M | |||||
North America | 83.91M | 121M | 121M | 126M | 138M | |||||
Total Assets | 104M | 125M | 109M | 125M | 128M | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | 797K | 1.09M | 1.66M | -253K | 1.25M | |||||
D&A | 939K | 1.01M | 970K | 883K | - | |||||
CAPEX | -134K | -276K | -220K | -1.03M | -8.16M | |||||
Net Income | 2.14M | 4.14M | 3.74M | -450K | 3.63M | |||||
Operating Income | 3.07M | 5.58M | 5.77M | -491K | 5.51M | |||||
Europe (excluding France) | 112M | 126M | 123M | 124M | 121M | |||||
Total Assets | 103M | 101M | 102M | 101M | 105M | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | 1.46M | 2.06M | 1.09M | 1.79M | 1.99M | |||||
D&A | 2.29M | 2.38M | 2.91M | 1.83M | - | |||||
CAPEX | -874K | -721K | -769K | -562K | -618K | |||||
Net Income | 3.83M | 6.72M | 4.83M | 6.16M | 5.94M | |||||
Operating Income | 5.3M | 8.45M | 5.32M | 7.21M | 7.22M | |||||
Other Countries | 10.2M | 15.12M | 16.28M | 21.97M | 27.24M | |||||
Total Assets | 9.37M | 12.46M | 17.88M | 17.44M | 20.61M | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | 117K | 232K | 613K | 517K | -137K | |||||
D&A | 260K | 301K | 220K | 429K | - | |||||
CAPEX | -90K | -112K | -347K | -617K | -64K | |||||
Net Income | -1.1M | -2.12M | -1.94M | -2.1M | -1.48M | |||||
Operating Income | -918K | -1.21M | -717K | -906K | -825K | |||||
Eliminations | -77.46M | -123M | -109M | -126M | -130M | |||||
Total Assets | -193M | -224M | -212M | -231M | -227M | |||||
Income Tax Expense | 2.43M | -496K | 525K | -1.07M | -761K | |||||
Net Income | 6.98M | -1.42M | 1.51M | -3.07M | -2.18M | |||||
Operating Income | 9.4M | -1.92M | 2.03M | -4.14M | -2.94M |
- Stock Market
- Stocks
- BOI Stock
- Financials BOIRON
- Business Segments
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
